Register for SOSV Deep Tech Live – Dr. Rick Gottscho on Plasma & Semiconductors

Ten63 Therapeutics

In silico drug design based on movement

Company details

Ten63 Therapeutics improves human health by developing potent therapeutics against medically-validated, yet “undruggable” targets. We do this by combining low-residual, ML-based computational chemistry and mathematically-guaranteed, superlinear search algorithms to find optimized drug candidates when no one else can.

Currently only 2-4% of drug targets are both druggable and disease modifying

Ten63 Therapeutics Quote Image
Marcel Frankel, PhD, CEO
Our software has made it possible — for the first time — to discover how a tumor will mutate, years before it actually happens in a patient. We can “discover” it while we are designing the drug itself in the computer. And so we can design drugs that work not just against the tumor before it mutates, but the drug will still work after it mutates. And not just one mutation — all likely mutations.

Get In Touch with Ten63 Therapeutics

Please tell us a little bit about yourself and why you'd like to get connected. Ten63 Therapeutics + SOSV will follow up with you via email.

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.